Annual report [Section 13 and 15(d), not S-K Item 405]

Consolidated Statements of Operations

v3.25.4
Consolidated Statements of Operations - USD ($)
$ in Thousands
12 Months Ended
Oct. 31, 2025
Oct. 31, 2024
Income Statement [Abstract]    
Revenue
Operating costs and expenses:    
Research and development expenses (including non-cash stock-based compensation expenses of $1,560 and $1,859, respectively) 5,071 6,396
General and administrative expenses (including non-cash stock-based compensation expenses of $2,250 and $2,923, respectively) 6,630 7,435
Total operating costs and expenses 11,701 13,831
Loss from operations (11,701) (13,831)
Interest income 673 1,133
Net loss (11,028) (12,698)
Less: Net loss attributable to noncontrolling interest (101) (144)
Net loss attributable to common shareholders $ (10,927) $ (12,554)
Net loss per share:    
Basic $ (0.34) $ (0.39)
Diluted $ (0.34) $ (0.39)
Weighted average common shares outstanding:    
Basic 32,454 31,898
Diluted 32,454 31,898